Lee June 4

Accession 0000899243-19-026147

CIK 0001552451other

View on SEC.gov Company Profile

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 8:31 PM ET

Size

44.6 KB

Accession

0000899243-19-026147

Insider Transaction Report

Form 4

Period: 2018-05-02

MyoKardia IncMYOK

Lee June

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2018-05-09$11.95/sh+4,500$53,775→ 14,110 total
Exercise/Conversion
Common Stock
2018-05-31$11.95/sh+364$4,350→ 14,474 total
Exercise/Conversion
Common Stock
2018-07-10$11.95/sh+364$4,350→ 14,838 total
Exercise/Conversion
Common Stock
2018-10-11$11.95/sh+2,500$29,875→ 18,429 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-07-10−364→ 104,932 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-10-01−364→ 103,841 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Common Stock
2018-05-02$11.95/sh+5,457$65,211→ 9,610 total
Exercise/Conversion
Common Stock
2018-08-09$11.95/sh+363$4,338→ 15,201 total
Exercise/Conversion
Common Stock
2018-09-04$11.95/sh+364$4,350→ 15,565 total
Exercise/Conversion
Common Stock
2018-10-01$11.95/sh+364$4,350→ 15,929 total
Exercise/Conversion
Common Stock
2019-02-25$11.95/sh+3,000$35,850→ 22,157 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-05-31−364→ 105,296 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-12-03−364→ 100,613 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-09-04−364→ 104,205 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-10-11−2,500→ 101,341 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (2,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-11-06−364→ 100,977 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (364 underlying)
Exercise/Conversion
Common Stock
2018-11-06$11.95/sh+364$4,350→ 18,793 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-05-02−5,457→ 110,160 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (5,457 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-05-09−4,500→ 105,660 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (4,500 underlying)
Exercise/Conversion
Common Stock
2018-12-03$11.95/sh+364$4,350→ 19,157 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-08-09−363→ 104,569 total
Exercise: $11.95Exp: 2027-01-31→ Common Stock (363 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-25−3,000→ 3,250 total
Exercise: $11.95From: 2018-06-28Exp: 2027-01-31→ Common Stock (3,000 underlying)

Footnotes (2)

[F1]25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
[F2]On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MyoKardia Inc

CIK 0001552451

→

Entity typeother

Related Parties

filerCIK 0001696493

Filing Metadata

Form type: 4
Filed: Oct 28, 8:00 PM ET
Accepted: Oct 29, 8:31 PM ET
Size: 44.6 KB

View on SEC.gov